Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Carbone

Showing results (451-460 of 651) with videos related to

Pageof 66
Sort By:
Lung Cancer (Amsterdam, Netherlands)|October 14, 2021
Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancerMin Li, Chunliu Zhang, Shichao Deng, et al.
Seminars in Oncology|August 1, 1997
Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I studyD I Rosenthal, O Okani, J Corak, et al.
Cancer|January 15, 1980
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology GroupE Z Ezdinli, W G Costello, F Icli, et al.
Molecular Endocrinology (Baltimore, Md.)|February 6, 2010
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signalingYujun Gan, Yue Zhang, Douglas J Digirolamo, et al.
Clinical Lung Cancer|August 18, 2016
Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims AnalysisTasneem Lokhandwala, Marisa A Bittoni, Robert A Dann, et al.
Cancer|September 1, 1976
Combination chemotherapy of the malignant lymphomas: a controlled clinical trialR E Lenhard, R L Prentice, A H Owens, et al.
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.
Cancer Treatment Reports|January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)D F Chiuten, J M Bennett, R H Creech, et al.
Science (New York, N.Y.)|February 18, 2014
Precise and ultrafast molecular sieving through graphene oxide membranesR K Joshi, P Carbone, F C Wang, et al.
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
Pageof 66

Showing results (451-460 of 651) with videos related to

Sort By:
Pageof 66
Lung Cancer (Amsterdam, Netherlands)|October 14, 2021
Lung cancer-associated T cell repertoire as potential biomarker for early detection of stage I lung cancerMin Li, Chunliu Zhang, Shichao Deng, et al.
Seminars in Oncology|August 1, 1997
Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I studyD I Rosenthal, O Okani, J Corak, et al.
Cancer|January 15, 1980
Nodular mixed lymphocytic-histiocytic lymphoma (NM): response and survival. Eastern Cooperative Oncology GroupE Z Ezdinli, W G Costello, F Icli, et al.
Molecular Endocrinology (Baltimore, Md.)|February 6, 2010
Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signalingYujun Gan, Yue Zhang, Douglas J Digirolamo, et al.
Clinical Lung Cancer|August 18, 2016
Costs of Diagnostic Assessment for Lung Cancer: A Medicare Claims AnalysisTasneem Lokhandwala, Marisa A Bittoni, Robert A Dann, et al.
Cancer|September 1, 1976
Combination chemotherapy of the malignant lymphomas: a controlled clinical trialR E Lenhard, R L Prentice, A H Owens, et al.
Cancer|January 1, 1986
A phase I/II investigation of trioxifene mesylate in advanced breast cancer. Clinical and endocrinologic effectsR S Witte, B Pruitt, D C Tormey, et al.
Cancer Treatment Reports|January 1, 1979
VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474)D F Chiuten, J M Bennett, R H Creech, et al.
Science (New York, N.Y.)|February 18, 2014
Precise and ultrafast molecular sieving through graphene oxide membranesR K Joshi, P Carbone, F C Wang, et al.
Clinical Lung Cancer|September 11, 2018
Incidence, Risk Factors, and Effect on Survival of Immune-related Adverse Events in Patients With Non-Small-cell Lung CancerDwight H Owen, Lai Wei, Erin M Bertino, et al.
Pageof 66